| Trial ID: | L4851 |
| Source ID: | NCT05806723
|
| Associated Drug: |
Atorvastatin 40 Mg Oral Tablet
|
| Title: |
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Dyslipidemia Associated With Type II Diabetes Mellitus|Statin Adverse Reaction|Hypogonadism, Male|Adrenal Insufficiency|Vitamin D Deficiency
|
| Interventions: |
DRUG: Atorvastatin 40 Mg Oral Tablet
|
| Outcome Measures: |
Primary: change in testosterone level after atorvastatin treatment, decrease in testosterone level, six months | Secondary: change in cortisol level after atorvastatin treatment, decrease in cortisol, six months|change in DHEAS levels after atorvastatin treatment, decrease in DHEAS, six months | Other: change in vitamin D level after atorvastatin treatment, decrease in vitamin D, six months
|
| Sponsor/Collaborators: |
Sponsor: Hopital La Rabta
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
104
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2021-03-01
|
| Completion Date: |
2022-09-15
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-10
|
| Locations: |
University Hospital La Rabta, Tunis, Tunisia
|
| URL: |
https://clinicaltrials.gov/show/NCT05806723
|
